BioWorld

Sep. 14, 2004

View Archived Issues

DNA Vaccine Might Provide Immunity Against Anthrax

Read More

FDA Panel Evaluates SSRIs, Risk Of Suicidal Thoughts

Read More

ID Biomedical's Government Contract Worth Up To C$30M

Read More

Other News To Note

Read More

Chiron Settles With Roche For $78M, Licenses IP To InterMune

Chiron Corp. finalized a settlement agreement with F. Hoffmann-La Roche Ltd. concerning an HIV patent late last week, then announced Monday an agreement to provide InterMune Inc. with its hepatitis C targets. (BioWorld Today) Read More

Threshold Starts Glufosfamide Phase III In Pancreatic Cancer

Read More